StoneCo reported strong revenue growth of 11% YoY and 7.5% QoQ, driven by financial revenues and a significant increase in processed volumes with micro, small, and medium-sized companies. Despite some cost pressures, margins were maintained with a gross margin increase of 0.8% YoY. The credit portfolio grew fourfold, though NPLs remain a concern. StoneCo achieved an adjusted net income of BRL 665.6 million in Q4 2024, up 18.1% YoY, and projected further growth in 2025 with a focus on capital returns.

LOS ANGELES , March 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against FMC Corporation ("FMC" or "the Company") (NYSE: FMC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 16, 2023 and February 4, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

LOS ANGELES , March 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intellia Therapeutics, Inc. ("Intellia" or "the Company") (NASDAQ: NTLA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 30, 2024 and January 8, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before April 14, 2025.

The sharp decline in the Nasdaq makes a leveraged bet on a tech stock turnaround potentially worth the risk. TECL ETF has dropped 35% in response to a 12% Nasdaq decline, presenting a potential short-term rebound opportunity. The 3x leveraged ETF is risky, but the odds of a significant market rally now outweigh the odds of a further downturn.

LOS ANGELES , March 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Elastic N.V. ("Elastic" or "the Company") (NYSE: ESTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

We recommend five small and mid-cap technology services stocks with huge short-term upside price potential. These are: BYRN, RAMP, DAVE, SMGZY, PATH.

SHEL aims to start gas production at Venezuela's Dragon field by 2026, a year ahead of schedule, it secures LNG supply for Trinidad amid shifting U.S. sanctions.

PBR partners with Baker Hughes to deploy intelligent completions technology, enhancing production and remote operations in Brazil's offshore fields.

The home improvement arena faces several hurdles. Among them are potential increases in the prices of key materials, particularly lumber from Canada.

FedEx Corp (NYSE:FDX, ETR:FDX) shares fell more than 9% in afterhours trading after the freight company's third quarter earnings missed expectations and it slashed its full-year profit outlook. For Q3, FedEx reported earnings per share (EPS) of $4.51, below estimates of $4.63.

NEW YORK, March 21, 2025 (GLOBE NEWSWIRE) -- Kaltura, Inc. (“Kaltura” or the “Company”) (Nasdaq: KLTR), the Video Experience Cloud, today announced that its Board of Directors has authorized a refreshed stock repurchase program for up to $15 million of the Company's common stock.

MIAMI , March 21, 2025 /PRNewswire/ -- Carnival Corporation & plc (NYSE/LSE: CCL; NYSE: CUK) announced financial results for the first quarter 2025 and provided an updated outlook for the full year and an outlook for the second quarter 2025. Record first quarter revenues of $5.8 billion, up over $400 million compared to the prior year.

Business Combination Agreement with CCTS originally announced in August 2024 Combined pro forma enterprise value of US$904m assumes no public trust redemptions for CCTS Parties working to close the transaction by Q2, calendar 2025 LONDON, March 21, 2025 (GLOBE NEWSWIRE) -- Tembo E-LV B.V. (“Tembo”), a subsidiary of Nasdaq-listed B Corporation, VivoPower International PLC (Nasdaq: VVPR) ("VivoPower" or the "Company"), today announced that it is working closely with CCTS (“Cactus Acquisition Corp. 1 Limited”), a Cayman Islands exempted special purpose acquisition company to progress towards a closing of the Business Combination by Q2, calendar 2025.

FORT LAUDERDALE, FLORIDA, March 21, 2025 (GLOBE NEWSWIRE) -- Bright Green Corporation (OTC: BGXX) (“Bright Green” or the “Company”) announced that on March 17, 2025, on behalf of the Company, Lynn Stockwell has asked the court to approve the “RSA” Restructuring Security Agreement, Disclosure Statement and Plan. The highlights of the Plan and Disclosure will provide new equity for the company to pay all creditors with approved claims in full, in addition the Company equity shareholders will retain their interests in the Company and are unimpaired with no dilution.

Scottsdale, Ariz., March 21, 2025 (GLOBE NEWSWIRE) -- CISO Global, Inc. (NASDAQ: CISO), an industry leader in AI-powered cybersecurity software, managed cybersecurity, and compliance, confirms that the recent volatility in its stock is not due to insider selling. The Company has confirmed that no Executive or Board Member has sold stock during this week's abnormal volatility. Additionally, the Company has not utilized the ATM facility in 2025.

The current market environment suggests a potential recession, leading investors to favor durable and income-producing assets. BDCs and REITs are likely to be among the key beneficiaries here. However, with REITs and especially BDCs investors have to be careful in order to avoid falling in a value trap.

SEATTLE--(BUSINESS WIRE)--Omeros Corporation (Nasdaq: OMER) today reported that clinical trial site activation for enrollment is underway for the company's Phase 3 program evaluating zaltenibart in paroxysmal nocturnal hemoglobinuria (PNH). Zaltenibart (OMS906) is Omeros' investigational inhibitor of MASP-3, the key and most proximal activator of the alternative pathway of complement. Zaltenibart inhibits the intravascular hemolysis treated by C5 inhibitors as well as the extravascular hemolysi.

Caleb Silver says we're no where near a recession, but market sentiment is at some of the lowest levels he's seen in years. In the tech sector rotation, he says individual investors are buying the dips on some of the biggest mega-cap tech stocks.

LOS ANGELES , March 21, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Grocery Outlet Holding Corp. ("Grocery Outlet" or "the Company") (NASDAQ: GO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between November 7, 2023 and May 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before March 31, 2025.

RADNOR, Pa., March 21, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Central District of California against The Trade Desk, Inc. (“Trade Desk”) (NASDAQ: TTD) on behalf of those who purchased or otherwise acquired Trade Desk Class A common stock or call options, or sold Trade Desk put options, between May 9, 2024, and February 12, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is April 21, 2025.